Indeed, systemic administration of PEGylated TRAIL was found to ameliorate carbon tetrachloride (CCl4) induced liver fibrosis and cirrhosis in rats, as measured by reductions in αSMA and collagen deposition, via selective killing of aHSCs without any off-target apoptosis. This evidence concerns the gene TNFSF10 and Hepatic fibrosis.